ARTICLE | Top Story
FDA approves pertuzumab for breast cancer
June 9, 2012 1:32 AM UTC
FDA approved a BLA from Genentech Inc. for Perjeta pertuzumab to treat previously untreated HER2-positive metastatic breast cancer in combination with Herceptin trastuzumab and docetaxel. Genentech, a...